文献速递血液净化与透析

多学科药物治疗管理与维持性透析患者30天再入院的关系:回顾性队列研究

Multidisciplinary Medication Therapy Management and Hospital Readmission in Patients Undergoing Maintenance Dialysis: A Retrospective Cohort Study.
PubMed 文献 · Am J Kidney Dis · 2020-03-12

该回顾性队列研究纳入2016年5月至2017年4月从急性病医院出院回家的维持性透析患者1452例次出院,评估多学科药物治疗管理(MTM)与30天再入院率的关联。结果显示,无MTM、部分MTM和完整MTM组的30天再入院率分别为29%、19%和11%(P<0.001),完整MTM与最低的30天再入院风险独立相关(HR 0.26,95%CI 0.15-0.45)。

要点

  • 完整MTM与30天再入院风险降低相关(HR 0.26,95%CI 0.15-0.45)。
  • 部分MTM亦与较低再入院风险相关(HR 0.50,95%CI 0.37-0.68)。
  • 倾向评分匹配敏感性分析结果一致(HR 0.20,95%CI 0.06-0.69)。

核心结论

  • 透析患者出院后接受MTM服务与较少的30天再入院相关。
  • 需要随机对照研究评估不同MTM实施模式及成本效益。

研究设计与样本

  • 回顾性队列研究,纳入1452例次维持性透析患者出院(2016年5月至2017年4月)。
  • 暴露分为无MTM(586例次)、部分MTM(704例次)和完整MTM(162例次)。
  • 采用时间依存性Prentice、Williams和Peterson总时间风险模型,并调整多变量。
  • 进行倾向评分匹配敏感性分析比较完整MTM与无MTM组。

主要发现

  • 30天再入院率:无MTM组29%,部分MTM组19%,完整MTM组11%(P<0.001)。
  • 与无MTM相比,完整MTM组30天再入院风险HR 0.26(95%CI 0.15-0.45)。
  • 部分MTM组再入院风险HR 0.50(95%CI 0.37-0.68)。
  • 倾向评分匹配后,完整MTM组30天再入院风险HR 0.20(95%CI 0.06-0.69)。

临床怎么用

  • 对维持性透析患者出院后实施包含护士药物核对、药师药物审核和肾科医生监督的多学科MTM可能降低30天再入院风险。
  • MTM实施完整性可能与再入院风险降低程度相关。

局限性

  • 基于观察性数据,存在残余偏倚和混杂。
  • 需要随机对照研究验证不同MTM交付模式及成本效益。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVES: Dialysis patients frequently experience medication-related problems. We studied the association of a multidisciplinary medication therapy management (MTM) with 30-day readmission rates. STUDY DESIGN: Retrospective cohort study. SETTING & PARTICIPANTS: Maintenance dialysis patients discharged home from acute-care hospitals between May 2016 and April 2017 who returned to End-Stage Renal Disease Seamless Care Organization dialysis clinics after discharge were eligible. Patients who were readmitted within 3 days, died, or entered hospice within 30 days were excluded. EXPOSURE: MTM consisting of nurse medication reconciliation, pharmacist medication review, and nephrologist oversight was categorized into 3 levels of intensity: no MTM, partial MTM (defined as an incomplete MTM process), or full MTM (defined as a complete MTM process). OUTCOME: The primary outcome was 30-day readmission. ANALYTICAL APPROACH: Time-varying Prentice, Williams, and Peterson total time hazards models explored associations between MTM and time to readmission after adjusting for age, race, sex, diabetes comorbidity, albumin level, vascular access type, kidney failure cause, dialysis vintage and modality, marital status, home medications, frequent prior hospitalizations, length of stay, discharge diagnoses, hierarchical condition category, and facility standardized hospitalization rates. Propensity score matching was performed to examine the robustness of the associations in a comparison between the full- and no-MTM exposure groups on time to readmission. RESULTS: Among 1,452 discharges, 586 received no MTM, 704 received partial MTM, and 162 received full MTM; 30-day readmission rates were 29%, 19%, and 11%, respectively (P < 0.001). Compared with no MTM, discharges with full MTM had the lowest time-varying risk for readmission within 30 days (HR, 0.26; 95% CI, 0.15-0.45); discharges with partial MTM also had lower readmission risk (HR, 0.50; 95% CI, 0.37-0.68). In propensity score-matched sensitivity analysis, full MTM was associated with lower 30-day readmission risk (HR, 0.20; 95% CI, 0.06-0.69). LIMITATIONS: Reliance on observational data. Residual bias and confounding. CONCLUSIONS: MTM services following hospital discharge were associated with fewer 30-day readmissions in dialysis patients. Randomized controlled studies evaluating different MTM delivery models and cost-effectiveness in dialysis populations are warranted.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Manley HJ, Aweh G, Weiner DE, et al. Multidisciplinary Medication Therapy Management and Hospital Readmission in Patients Undergoing Maintenance Dialysis: A Retrospective Cohort Study. Am J Kidney Dis. 2020. PMID: 32173107. doi:10.1053/j.ajkd.2019.12.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。